Review Article of American Journal of Histology and Cytology
Research on Brain Tumors in Mexico: A Bibliometric Analysis from Latin America
Rubio Carmen PhD1, Tena Martha M.D. 1, Rojas Daniel A. M.D. 1, Sotelo Julio, PhD. 1, Lee Angel M.D. 2
1Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico; 2Comisión Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad, Mexico City, Mexico
Background: Bibliometrics is a completive method of research and analyses useful to understand the collective contributions of a given scientific community. The detail of the quantity (productivity) and impact as a surrogate marker of quality can shed light on what we have done (number of articles) and how we impact others (citations). It also shows the direction the community can take for further research, guided by its shortcomings and successes. The publications of Latin American medical institutions on brain neoplasms have never been studied.
Objective: Analyze a clinical and experimental approach, identifying core journals, type of article, increase of published material with time, number of citations. Additionally, we identified the most researched topics involved in brain tumor literature.
Material and methods: We harvested the articles published by at least one author from the Instituto Nacional de Neurología y Neurocirugía from Mexico from its inception in 1964 to 2020. Key bibliometric parameters, as the journal of publication, type of paper, number of articles, and citations were recorded.
Results: In cerebral neoplasms, our institution produced 291 articles (clinical versus experimental: 227 vs. 64). With a modest productivity before 2000, the production had increased 8-fold by 2019. The main topic is glioblastoma, also with the highest number of citations. Researchers prefer to conduct original investigations rather than subject reviews. Most papers were published in Archivos de Neurociencias (institutional journal produced in Spanish), most papers published in English were in the Journal of Neuro-Oncology.
Discussion: Productivity had an encouraging growth in the last decade, but more emphasis should be given to target international journals, which offer a high number of readers and citations. Strategies to reach these goals have to be found and should be implemented.
Conclusion: Research on brain tumors in Mexico has recently shown buoyancy and we should profit from this inertia to give a definitive boost to it, which might benefit authors and institutional prestige. But mainly, with a more robust research, we could find better solutions for our patients, applicable in the national and international context.
Keywords: Bibliometric, México, Gliomas, Meningiomas, Medulloblastoma.
How to cite this article:
Rubio Carmen, Tena Martha, Rojas Daniel A., Sotelo Julio, Lee Ángel. Research On Brain Tumors In Mexico: A Bibliometric Analysis From The Latin America.American Journal of Histology and Cytology, 2022, 5:16. DOI: 10.28933/ajohc-2021-11-1205
References:
1. Luukkonen T. Bibliometrics and evaluation of research performance. Ann Med. 1990 Jun;22(3):145-50.
2. Ma L, Gao X, Liu W. Bibliometric analysis of the top-100 cited articles on oral potentially malignant disorders to guide research topic and direction. J Dent Sci. 2020 Dec;15(4):479-485.
3. American Society of Clinical Oncology (ASCO). Brain Tumor: Statistics. Available on: https://www.cancer.net/cancer-types/brain-tumor/statistics. Accessed May 2021.
4. Instituto Nacional de Estadística y Geografía (INEGI). Características de las defunciones registradas en México durante Enero a Agosto de 2020. Comunicado de prensa núm. 61/21. Available on: https://www.inegi.org.mx/app/saladeprensa/noticia.html?id=6244. Accessed May 2021.
5. Anaya-Delgadillo G, de Juambelz-Cisneros PP, Fernández-Alvarado B, Pazos-Gómez F, Velasco-Torre A, Revuelta-Gutiérrez R. Prevalencia de tumores del sistema nervioso central y su identificación histológica en pacientes operados: 20 años de experiencia [Prevalence of central nervous system tumours and histological identification in the operated patient: 20 years of experience]. Cir Cir. 2016 Nov-Dec;84(6):447-453.
6. Olivares L, Alter M, Márquez L, Cisneros L, Sánchez C. Epidemiología de los tumores cerebrales primarios en México. Estudio de la población del I.S.S.S.T.E. en el D. F [Epidemiology of primary cerebral tumors in Mexico. Study of the population of the Instituto de la Salud del Seguro Social de los Trabajadores del Estado in the Distrito Federal]. Salud Publica Mex. 1971 May-Jun;13(3):305-12.
7. Cancer Research UK. Brain, other CNS and intracranial tumours mortality statistics, Cancer Research UK. Available on: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/brain-other-cns-and-intracranial-tumours/mortality. Accessed May 2021.
8. Diéguez-Campa CE, Pérez-Neri I, Reyes-Terán G, Flores-Apodaca IA, Castillo-Ledón-Pretelini J, Mercado-Bautista O, et al. The 2020 research pandemic: A bibliometric analysis of publications on COVID-19 and their scientific impact during the first months. Arch Cardiol Mex. 2020 Nov 4.
9. Galván LC, Ríos N, Lansingh VC, Lee Á, Wu L, Lopez E. Analysis of ophthalmological and vision-related publications in Latin America. Arq Bras Oftalmol. 2018 Jan-Feb;81(1):24-29.
10. Rubio C, Luna R, Ibarra-Velasco M, Lee Á. Epilepsy: A bibliometric analysis (1968-2020) of the Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suarez” in Mexico. Epilepsy Behav. 2021 Feb;115:107676.
11. Contreras LE. Epidemiología de tumores cerebrales. Rev. méd. Clín. Las Condes. 2017 May-June;28(3):332-8.
12. Regalado A. Science in Brazil. Brazilian science: riding a gusher. Science. 2010 Dec 3;330(6009):1306-12.
13. Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2021 Mar;18(3):170-186.
14. Soriano Sánchez JA, Soriano Solis S, Soto Garcia ME, Romero Rangel JAI. Scientific Contributions of the Mexican Association of Spine Surgeons (Asociación Mexicana de Cirujanos de Columna-AMCICO) to the Global Medical Literature: A 21-Year Systematic Review. World Neurosurg. 2020 Jun;138:e223-e240.
15. Thakkar JP, Dolecek TA, Horbinski C, Ostrom QT, Lightner DD, Barnholtz-Sloan JS, Villano JL. Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1985-96.
16. Alexander BM, Cloughesy TF. Adult Glioblastoma. J Clin Oncol. 2017 Jul 20;35(21):2402-2409.
17. Tran B, Rosenthal MA. Survival comparison between glioblastoma multiforme and other incurable cancers. J Clin Neurosci. 2010 Apr;17(4):417-21.
Terms of Use/Privacy Policy/ Disclaimer/ Other Policies:
You agree that by using our site/services, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies (click here for details).
CC BY 4.0
This work and its PDF file(s) are licensed under a Creative Commons Attribution 4.0 International License.